Literature DB >> 25206074

Role of Ventromedial hypothalamus in high fat diet induced obesity in male rats: association with lipid profile, thyroid profile and insulin resistance.

Archana Gaur1, Gopal K Pal1, Palghat H Ananthanarayanan2, Parvati Pal1.   

Abstract

BACKGROUND: Ventromedial hypothalamus (VMH) plays a major role in food intake, obesity and energy homeostasis. There is a report of gender difference in energy balance with increased vulnerability of males to cardiac disease.
PURPOSE: Body metabolism is greatly influenced by the diet we eat and some of the blood parameters like plasma glucose, insulin, lipid profile and thyroid profile depict a picture of energy homeostasis of the body.
OBJECTIVE: The present study was conducted to assess the effect of VMH in high fat diet (HFD) induced obesity and its link with insulin, glucose, thyroid and lipid profile of male Wistar rats.
METHODS: The male rats (n = 12) were given HFD for a period of 10 weeks to induce obesity. After obtaining a basal recording of food intake, body weight, glucose, insulin, thyroid and lipid profile, animals were divided into control and experimental group (n = 6 male in each). Experimental rats underwent electrolytic ablation of VMH whereas control rats underwent sham lesion. A post-lesion recording was taken at the end of four weeks.
RESULTS: The rats had a greater food intake and more body weight gain after HFD schedule in both the groups. After VMH lesion, food intake increased further, only in experimental group. Plasma glucose, Insulin, HOMA - IR, total cholesterol (TC) and triglycerides (TG) were significantly increased compared to the pre-lesion values in experimental group (P<0.001).
CONCLUSIONS: Ten week of HFD resulted in obesity. VMH appears to prevent the development of insulin resistance and hypercholesterolemia which influences the energy homeostasis in male rats after high fat diet.

Entities:  

Keywords:  Energy homeostasis; HFD; Insulin resistance; Obesity; VMH lesion

Year:  2014        PMID: 25206074      PMCID: PMC4158776          DOI: 10.5214/ans.0972.7531.210306

Source DB:  PubMed          Journal:  Ann Neurosci        ISSN: 0972-7531


Introduction

Obesity is defined as a derangement in energy homeostasis leading to an excessive accumulation of adipose tissue, a significant risk to health. The increasing prevalence of overweight and obesity, coupled with their associations with disability and disease, has led to their identification as a potentially preventable cause of premature morbidity and death.[1] Body weight is determined by an interaction between genetic, environmental and psychosocial factors.[2] These influences ultimately act by changing the energy balance equation, that is, the long-term balance between energy intake and expenditure. Excess intake of food is one of the risk factors for obesity. A study based on gene-expression profiling suggested that diet induced obese rats in general represent an appropriate obesity model.[3] Therefore, in present study, high fat diet (HFD) was used to create the obese model in rats. VMH is designated as the principal satiety center governing feeding behavior.[4] Established pathways involving orexigenic neuropeptide Y (NPY) and agouti-related polypeptide (AgRP) (NPY/AgRP); and the anorexigenicpro-opiomelanocortin (POMC) and cocaine and amphetamine-related transcript (CART) (POMC/CART) neurons project from the arcuate nucleus (AR) to other important hypothalamic nuclei, including the paraventricular (PVN), dorsomedial (DMN), VMH and LH nuclei.[5] In addition, there are many projections to and from the brainstem, cortical areas and reward pathways, which modulate food intake. Neuronal pathways between these nuclei are organized into a complex network in which orexigenic and anorexigenic circuits influence food intake and energy expenditure.[5] The obese males develop atherosclerotic disease and myocardial lesions while obese females and lean rats do not.[6] Body metabolism is greatly influenced by the diet we eat and some of the blood parameters like plasma glucose, insulin, lipid profile and thyroid profile depict a picture of energy homeostasis of the body. In the present study, we assessed the effect of VMH in HFD - induced obesity of male rats and its association with the biochemical parameters.

Methods

The study was conducted after obtaining approval of the JIPMER Scientific Advisory Committee and JIPMER Institutional Animal Ethics Committee. Twelve institute-bred healthy adult male albino rats of Wistar strain weighing between 150–250 g were obtained for the study. The rats were housed in individual plastic cages with wire lids. Twelve hour light–dark cycle was maintained. They were fed standard rat chow and allowed to habituate in their cage for 10 days. The rats were fed on HFD for 10 weeks,[7] prepared freshly each day.

Composition of HFD[7]

HFD and water were provided ad-libitum. At the end of 10 weeks when all the rats turned obese, the diet was changed to standard rodent chow and water ad libitum. Following this, daily food intake and body weight was measured with the help of analytical weighing balance for one week and the average was taken to determine the 24 hour basal recordings. The rats were then divided into two groups, experimental and control with six rats in each group. After one week of acclimatization to the lab environment, the experimental group underwent electrolytic ablation of VMH bilaterally and in control group, sham lesions were made, that is needle was passed into the VMH nucleus without passing any electric current. The location of the VMH was identified using co-ordinates from the stereotaxic atlas for rat brain by König and Klippel, 1963. The procedure was performed in anaesthetized (ketamine 40 mg/kg b.w. i.p.) animals. Daily food intake and body weight was measured after lesion for four weeks and the average was taken.

Biochemical Parameters

About 2ml of blood was collected from tail vein before the lesion and at the end of four weeks blood was obtained by cardiac puncture after the lesion for the biochemical parameters recording. The animals were sacrificed thereafter. Fasting plasma glucose (glucose oxidase peroxidase method), fasting plasma insulin (rat/ mouse Insulin ELISA kit, MilliporeTM, USA), lipid profile viz, Total Cholesterol (TC), triglycerides (TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL), very-low density lipoprotein (VLDL) (chemiluminescenceit, Siemens, USA), plasma TSH (Human TSH chemiluminescence Kit, Siemens, USA), total triiodothyronine (Human TT3 RIA kit, ImmunotechTM, Czech) and totalthyroxine (Human TT4 RIA Kit, ImmunotechTM, Czech) were measured. HOMA - IR, an index of insulin resistance assessed by the homeostasis model assessment was calculated as follows: HOMA- IR = Fasting insulin (μU/ml) x Fasting plasma glucose (mmol/l)/22.5.[8]

Statistical Analysis

For data analysis, all values were expressed as mean ± SD. Differences between means were compared by Student’s t test (paired and unpaired) using Graph pad In Stat (Version 3, USA) software. P<0.05 was considered statistically significant.

Results

In control and experimental rats, food intake and body weight before the start of experiment was comparable (Table 1). After giving HFD diet, the food intake and body weight increased in both the groups.
Table 1:

Comparison of food intake (FI) and body weight (BW) of male rats (n = 6) before giving high fat diet (HFD).

ParameterControlExperimentalP value
Data expressed as mean ± SD, HFD group is the group given high fat diet. The * represents comparison with control males, The analysis of data was done by unpaired ‘t’ test. *p<0.05; **p<0.01; ***p<0.001.
FI (g/day)11.56 ± 1.6411.96 ± 1.800.6959
BW (g)217.70 ± 20.456212.20 ± 15.800.6136
Before undergoing lesion, both control and experimental group did not differ significantly in food intake and body weight. Similarly, no significant difference was observed in biochemical parameters (Table 2).
Table 2:

Comparison of food intake (FI), body weight (BW) & biochemical parameters of control (rats selected for sham lesion) and experimental (rats selected for VMH lesion) in male rats before lesion.

ParameterControl (n = 6)Experimental (n = 6)P value
Data expressed as mean ± SD, HFD group is the group given high fat diet. The *represents comparison with control males, The analysis of data was done by unpaired ‘t’ test. *p<0.05; **p<0.01; ***p<0.001.
FI (g/day)14.14 ±2.03515.936 ±2.8010.2326
BW(g)285.66 ±19.098292.83 ±18.3580.5223
Plasma Glucose (mg/dl)116.66 ±16.621108.83 ±8.2080.3252
Insulin (ng/ml)3.069 ±0.8542.096 ±0.7570.0633
HOMA IR17.200 ±3.62613.519 ±2.1250.0575
TC (mg/dl)80.0 ±4.09978.33 ±8.710.6799
TG (mg/dl)75.33 ±10.18477.16 ±13.740.7986
HDL (mg/dl)21.33 ±3.07722.83 ±4.3550.5065
LDL (mg/dl)36.6 ±6.49538.7 ±7.4730.6147
VLDL (mg/dl)23.06 ±5.83729.43 ±6.3490.1005
TSH ((μIU/ml)0.861 ±0.1431.13 ±0.3570.1174
T3 (ng/dl)0.95 ±0.2651.102 ±0.5600.5612
Thyroxine (μg/dl)5.27 ±4.7473.842 ±1.8300.5074

Effect of lesion

Comparison of experimental group with control group

There was a significant increase in food intake (p<0.05) and body weight (p<0.001) following lesion in experimental group (Table 3). Though there was increase in fasting plasma glucose and insulin, the increase was significant only for insulin (p<0.05) (Table 3). HOMA - IR increased significantly (p<0.05) (Table 3). There was a significant increase in total cholesterol and triglycerides (p<0.001) (Table 3).
Table 3:

Comparison of food intake (FI), body weight (BW) & biochemical parameters of control (rats selected for sham lesion) and experimental (rats selected for VMH lesion) in male rats after lesion.

ParameterControl (n = 6)Experimental (n = 6)P value
Data expressed as mean ± SD, HFD group is the group given high fat diet. The * represents comparison with control males, The analysis of data was done by unpaired ‘t’ test. *p<0.05; **p<0.01; ***p<0.001.
FI (g/day)14.98 ±1.56518.928 ±1.979*0.0033
BW (g)293.5 ±14.927362.66 ±16.20***<0.0001
Plasma Glucose (mg/dl)145.52 ±35.138169.66 ±22.9320.1891
Insulin (ng/ml)2.996 ±0.8924.48 ±1.025*0.0233
HOMA IR25.815 ±4.71745.006 ±15.651*0.0165
TC (mg/dl)106.0 ±7.314152.83 ±11.210***<0.0001
TG (mg/dl)65.83 ±5.212104.83 ±5.193***<0.0001
HDL (mg/dl)19.16 ±4.40120.66 ±2.5030.4847
LDL (mg/dl)29.66 ±8.35025.2 ±5.0150.2882
VLDL (mg/dl)27.16 ±2.64226.96 ±4.0390.9212
TSH ((μIU/ml)1.76 ±1.0901.925 ±1.1930.8076
T3 (ng/dl)0.753 ±0.2420.851 ±0.6470.7354
Thyroxine (μg/dl)3.564 ±1.7194.036 ±2.2080.6882

Comparison of post lesion values with pre-lesion values in experimental group

Though there was increase in both food intake and body weight, body weight increase was significant (p<0.001) following lesion. Fasting plasma glucose, insulin, HOMA - IR, TC and TG levels were significantly increased (p<0.001) (Table 4). HDL and VLDL did not show any significant difference, but LDL was significantly decreased (p<0.01), (Table 4). Thyroid profile did not show any significant change (Table 4).
Table 4:

Comparison of food intake (FI), body weight (BW) & biochemical parameters of control (rats selected for sham lesion) in both male rats before & after lesion.

ParameterPre-lesion (n = 6)Post-lesion (n = 6)P value
Data expressed as mean ± SD, HFD group is the group given high fat diet. The * represents comparison with pre- lesion, The analysis of data was done by paired ‘t’ test. *p<0.05; **p<0.01; ***p<0.001.
FI (g/day)15.936 ±2.80118.928 ±1.970.0583
BW (g)292.83 ±18.358362.66 ±16.20***<0.0001
Plasma Glucose (mg/dl)108.83 ±8.208169.66 ±22.932***0.0001
Insulin (ng/ml)2.096 ±0.7574.48 ±1.025***0.0010
HOMA IR13.519 ±2.12545.006 ±15.651***0.0006
TC (mg/dl)78.33 ±8.71152.83 ±11.210***<0.0001
TG (mg/dl)77.16 ±13.74104.83 ±5.193***0.0010
HDL (mg/dl)22.83 ±4.35520.66 ±2.5030.3149
LDL (mg/dl)38.7 ±7.47325.2 ±5.015**0.0043
VLDL (mg/dl)29.43 ±6.34926.96 ±4.0390.4401
TSH ((μIU/ml)1.13 ±0.3571.925 ±1.1930.1489
T3 (ng/dl)1.102 ±0.5600.851 ±0.6470.4889
Thyroxine (μg/dl)3.842 ±1.8304.036 ±2.2080.8717

Discussion

VMH has long been considered as the major brain structure for appetite control in energy homeostasis. Lesion of VMH leads to hyperphagia and morbid obesity, which is called as ‘hypothalamic obesity’.[9] But the role of VMH on food intake and body weight in already obese individuals has not been fully delineated. In the present study, we observed an increase in body weight after lesion even in HFD-induced obese rats. Hence, VMH lesion can lead to further increase in body weight irrespective of the initial body weight in obese rats. The role of VMH on satiety and body weight control has been reassessed and it has been proposed that VMH-lesion obesity is in large a metabolic obesity due to autonomic dysfunctions independent of hyperphagia.[10] We have not measured the autonomic parameters in this study, but we noted a significant increase in food intake after lesion in study group. Hence, the mechanism of hyperphagia as a cause of increased body weight after VMH lesion cannot be ruled out. Anorexigens like insulin and leptin act on arcuate nucleus and paraventricular nucleus to increase sympathetic activity and energy expenditure and decrease food intake.[11] However, the observation that the increase in body weight and food intake after VMH lesion alone, could be due to the fact that VMH acts as the final common pathway controlling the feeding behavior cannot be concluded as there are other hypothalamic areas regulating feeding. Important parameters of energy homeostasis are levels of plasma glucose and insulin. There was a significant increase in insulin level following VMH lesion which is in corroboration with the previous studies.[9,12-16] In the present study, though there was an increase in plasma glucose concentration, it was not significant when compared to controls. However, the plasma glucose concentration was significantly increased compared to pre-lesion values. Many reports state that normal serum glucose level, in the presence of hyperinsulinemia suggests insulin resistance.[13,15] Hence, in the present study experimental rats were in the insulin resistant state after VMH lesion. This is further supported by the significant increase in HOMA – IR compared to the controls as well as pre-lesion values. Suga et al showed that despite a marked adiposity and hyperinsulinemia, insulin resistance was not increased in VMH-lesioned rats whereas fructose diet brought about substantial insulin resistance and hyperinsulinemia in both lean and obese rats.[17] This difference could be due to the type of diet given. Thus, it appears that following VMH lesion, HFD induced obese male rats are susceptible to insulin resistance. In the present study, serum cholesterol in experimental rats was significantly increased following VMH lesion, which indicates that VMH has a cholesterol suppressing effects in high-fat induced obesity. Following lesion, triglyceride was significantly increased inexperimental rats (Table 4). Our findings are in conformity with the previous report that VMH lesion causes hypertriglyceridemia.[18] Another study suggests that lipoprotein synthesis markedly increases in the livers of VMH lesioned rats.[19] From the findings of the present study, it is proposed that VMH has an inhibitory effect on triglycerides and cholesterol in males and the effect is reduced after lesion. Thus, our study suggests increased susceptibility of obese male rats to insulin resistance and dyslipidemia. Thyroid hormone largely influences energy balance of the body. Our study did not show any significant difference in TSH, T3 and thyroxinelevels in experimental rats following VMH lesion compared to that of control rats.

Conclusion

VMH is the important center for satiety and adiposity and could be the ultimate pathway for control of food intake and obesity. The mechanism of hyperphagia as a cause of increased body weight after VMH lesion could be the possible mechanism for obesity. VMH lesion can lead to further increase in body weight in HFD-induced obese rats. VMH appears to prevent the development of insulin resistance. The present study reveals the susceptibility of male rats on HFD to insulin resistance, adiposity and hyperlipidemia after VMH lesion.
Itemg/Kg of diet
Casein164
Corn starch303.1
Dextrose115
Sucrose89.9
Butter oil190
Cellulose58.6
Soyabean oil10
Mineral mix41
Vitamin mix11.7
L-Cysteine2.1
Choline bitartate2.9
  16 in total

Review 1.  Health risks associated with overweight and obesity.

Authors:  P Kopelman
Journal:  Obes Rev       Date:  2007-03       Impact factor: 9.213

2.  In vivo metabolic changes as studied longitudinally after ventromedial hypothalamic lesions.

Authors:  L Pénicaud; F Rohner-Jeanrenaud; B Jeanrenaud
Journal:  Am J Physiol       Date:  1986-06

3.  Effect of vagotomy on serum insulin in rats with paraventricular or ventromedial hypothalamic lesions.

Authors:  K Tokunaga; M Fukushima; J W Kemnitz; G A Bray
Journal:  Endocrinology       Date:  1986-10       Impact factor: 4.736

4.  Insulin resistance and impaired glucose tolerance in the atherosclerosis-prone LA/N corpulent rat.

Authors:  J C Russell; S K Ahuja; V Manickavel; R V Rajotte; R M Amy
Journal:  Arteriosclerosis       Date:  1987 Nov-Dec

5.  Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas.

Authors:  M Emoto; Y Nishizawa; K Maekawa; Y Hiura; H Kanda; T Kawagishi; T Shoji; Y Okuno; H Morii
Journal:  Diabetes Care       Date:  1999-05       Impact factor: 19.112

6.  Plasma leptin levels and triglyceride secretion rates in VMH-lesioned obese rats: a role of adiposity.

Authors:  A Suga; T Hirano; S Inoue; M Tsuji; T Osaka; Y Namba; M Miura; M Adachi
Journal:  Am J Physiol       Date:  1999-04

7.  Effects of fructose and glucose on plasma leptin, insulin, and insulin resistance in lean and VMH-lesioned obese rats.

Authors:  A Suga; T Hirano; H Kageyama; T Osaka; Y Namba; M Tsuji; M Miura; M Adachi; S Inoue
Journal:  Am J Physiol Endocrinol Metab       Date:  2000-04       Impact factor: 4.310

8.  Assessment of diet-induced obese rats as an obesity model by comparative functional genomics.

Authors:  Shuyu Li; Hong-Yan Zhang; Charlie C Hu; Frank Lawrence; Kelly E Gallagher; Anupama Surapaneni; Shawn T Estrem; John N Calley; Gabor Varga; Ernst R Dow; Yanyun Chen
Journal:  Obesity (Silver Spring)       Date:  2008-01-24       Impact factor: 5.002

9.  Obesity in adulthood and its consequences for life expectancy: a life-table analysis.

Authors:  Anna Peeters; Jan J Barendregt; Frans Willekens; Johan P Mackenbach; Abdullah Al Mamun; Luc Bonneux
Journal:  Ann Intern Med       Date:  2003-01-07       Impact factor: 25.391

Review 10.  Hypothalamic and genetic obesity: an appraisal of the autonomic hypothesis and the endocrine hypothesis.

Authors:  G A Bray
Journal:  Int J Obes       Date:  1984
View more
  6 in total

1.  Correlation of TLR4 and KLF7 in Inflammation Induced by Obesity.

Authors:  Cuizhe Wang; Xiaodan Ha; Wei Li; Peng Xu; Yajuan Gu; Tingting Wang; Yan Wang; Jianxin Xie; Jun Zhang
Journal:  Inflammation       Date:  2017-02       Impact factor: 4.092

2.  Role of Ventromedial Hypothalamus in Sucrose-Induced Obesity on Metabolic Parameters.

Authors:  Archana Gaur; G K Pal; Pravati Pal
Journal:  Ann Neurosci       Date:  2021-05-21

Review 3.  Neuroprotective Effect of SGLT2 Inhibitors.

Authors:  Agnieszka Pawlos; Marlena Broncel; Ewelina Woźniak; Paulina Gorzelak-Pabiś
Journal:  Molecules       Date:  2021-11-28       Impact factor: 4.411

Review 4.  From Reductionism Toward Integration: Understanding How Social Behavior Emerges From Integrated Circuits.

Authors:  Sarah Y Dickinson; Diane A Kelly; Stephanie L Padilla; Joseph F Bergan
Journal:  Front Integr Neurosci       Date:  2022-04-01

5.  Evaluation of Diabetogenic Mechanism of High Fat Diet in Combination with Arsenic Exposure in Male Mice.

Authors:  Akram Ahangarpour; Soheila Alboghobeish; Mohsen Rezaei; Mohammad Javad Khodayar; Ali Akbar Oroojan; Marzieh Zainvand
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

Review 6.  The role of thyroid hormone in metabolism and metabolic syndrome.

Authors:  Patrícia de Fátima Dos Santos Teixeira; Patrícia Borges Dos Santos; Carmen Cabanelas Pazos-Moura
Journal:  Ther Adv Endocrinol Metab       Date:  2020-05-13       Impact factor: 3.565

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.